Marisa Austin
Acute Care · Germantown, TNNPI 1528207594
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 631 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 631 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Novartis$2K
- Impulse Dynamics (USA) Inc.$1K
- Boehringer Ingelheim$807
- Merck$625
- AstraZeneca$594
- plus $3K from 25 others
What the payments were for
- Travel & lodging$6036%
- Food & beverage$9,39594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 133 | $1,939 |
| Novartis | 188 | $1,839 |
| Impulse Dynamics (USA) Inc. | 10 | $1,165 |
| Boehringer Ingelheim | 64 | $807 |
| Merck | 36 | $625 |
| AstraZeneca | 21 | $594 |
| Bayer | 37 | $460 |
| Johnson & Johnson | 29 | $446 |
| Novo Nordisk | 14 | $301 |
| Pfizer | 16 | $289 |
| E.r. Squibb & Sons, L.L.C. | 15 | $270 |
| Bridgebio Pharma, Inc. | 7 | $243 |
| Alnylam Pharmaceuticals Inc. | 6 | $142 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $101 |
| Cvrx, Inc. | 5 | $101 |
| Esperion Therapeutics, Inc. | 6 | $91 |
| Boston Scientific | 2 | $77 |
| Amarin Pharma, Inc. | 6 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| Lexicon Pharmaceuticals, Inc. | 3 | $49 |
| Vivaquant Inc, Dba Rhythm Express | 5 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| Abbott | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $16 |
| Silk Road Medical, Inc. | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Bardy Diagnostics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,999 in reported general payments places this provider in the 95th percentile of 738 acute care providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 150 | $155,163 |
| XareltoRivaroxaban | 79 | $87,353 |
| EntrestoSacubitril/Valsartan | 32 | $47,503 |
| JardianceEmpagliflozin | 27 | $36,383 |
| FarxigaDapagliflozin Propanediol | 17 | $20,685 |
| Repatha SureclickEvolocumab | 20 | $15,192 |
| Ezetimibe | 176 | $5,929 |
| Metoprolol Succinate | 353 | $5,352 |
| Rosuvastatin Calcium | 373 | $5,024 |
| Nebivolol Hcl | 77 | $4,406 |
| Atorvastatin Calcium | 262 | $2,470 |
| Amlodipine Besylate | 272 | $2,418 |
| Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid | 27 | $2,391 |
| Telmisartan | 73 | $2,050 |
| Losartan Potassium | 153 | $1,707 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $289 | $155,163150 claims |
| Johnson & JohnsonXarelto | $446 | $87,35379 claims |
| NovartisEntresto | $1,839 | $47,50332 claims |
| Boehringer IngelheimJardiance | $807 | $36,38327 claims |
| AstraZenecaFarxiga | $594 | $20,68517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 738 acute care providers in Tennessee.
Other acute care in Germantown
- Laura SmithGermantown$11K
- Linda DiepGermantown$7K
- Haley HoyNashville$368K
- Anne AlexandrovMemphis$110K
- Stephen MillerKnoxville$108K
- Shannon GraceNashville$57K
- Timothy BallardKnoxville$47K
- Kelsey MartinNashville$42K
- Barbara BrownNashville$36K
- Michelle GoochChattanooga$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.